ELVHealthcareLarge-Cap

Elevance Health, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Elevance Health, Inc. (ELV), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ELV insiders buying or selling?

Elevance Health, Inc. insiders reported 8 open-market buys ($8.1M) and 83 sells ($199.7M) across 91 Form 4 filings — a net selling position of $191.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 17, 2026)

Total Form 4 filings
91
SEC EDGAR
Insider filers
19
Insider buys (8)
$8.1M
Insider sells (83)
$199.7M

Insider sentiment

Net selling

Net insider flow of $191.6M in net selling. 2 insider buys in the last 90 days.

Recent ELV insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 17, 2026Ramiro G PeruDirectorPurchase1.0K$366.05$366.1K
Jul 17, 2026Gail BoudreauxPresident and CEOPurchase2.7K$367.79$1.0M
Jun 15, 2026Ronald W PenczekCAO & ControllerSale369$403.16$148.8K
Jun 12, 2026Robert L Dixon JRDirectorSale151$401.77$60.7K
May 20, 2026Ronald W PenczekCAO & ControllerSale1.5K$403.13$617.2K
Mar 23, 2026Amy W SchulmanDirectorSale26$287.50$7.5K
Mar 9, 2026Charles Morgan Kendrick JREVP & President, CommercialSale3.2K$284.92$910.6K
Mar 6, 2026Steven H CollisDirectorPurchase3.0K$289.84$869.5K
Aug 21, 2025Susan D. DevoreDirectorPurchase1.2K$312.15$374.6K
Jul 18, 2025Gail BoudreauxPresident and CEOPurchase8.5K$286.94$2.4M
Apr 25, 2025Mark KayeEVP & CFOSale4.6K$424.82$1.9M
Mar 11, 2025Ronald W PenczekCAO & ControllerSale443$415.13$183.9K
Mar 5, 2025Charles Morgan Kendrick JREVP & President, CommercialSale3.5K$396.30$1.4M
Oct 18, 2024Charles Morgan Kendrick JREVP & President, CommercialSale7.4K$432.14$3.2M
Aug 6, 2024Ramiro G PeruDirectorSale753$531.52$400.2K
Jul 23, 2024Gail BoudreauxPresident and CEOSale34.0K$500.98$17.0M
Jul 22, 2024Robert L Dixon JRDirectorSale305$506.76$154.6K
Apr 25, 2024Felicia F NorwoodEVP & President,Gov Health BenSale20.3K$533.34$10.8M
Mar 12, 2024Charles Morgan Kendrick JREVP & President, CommercialSale2.4K$500.46$1.2M
Mar 8, 2024Ronald W PenczekCAO & ControllerSale916$504.58$462.2K
Mar 5, 2024Peter D HaytaianEVP & Pres Carelon & CarelonRxSale21.1K$500.18$10.6M
Feb 9, 2024Ramiro G PeruDirectorSale753$500.00$376.5K
Dec 15, 2023Blair Williams TodtEVP, CLO & CAOSale5.5K$484.02$2.7M
Dec 1, 2023Ronald W PenczekCAO & ControllerSale1.1K$475.17$501.3K
Oct 26, 2023Ronald W PenczekCAO & ControllerSale64$454.35$29.1K

Showing the 25 most recent of 91 Form 4 filings for Elevance Health, Inc..

Most active ELV insiders

  • Peter D Haytaian19 filings
  • Ronald W Penczek16 filings
  • Ramiro G Peru8 filings
  • Robert L Dixon JR8 filings
  • Julie A Hill7 filings

Ask anything about ELV insider activity

Use Trabud's AI agent to query Elevance Health, Inc.'s Form 4 history in plain English — "Show me ELV CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ELV insider trading FAQ

Are Elevance Health, Inc. insiders buying or selling?

Across 91 SEC Form 4 filings, Elevance Health, Inc. (ELV) insiders reported 8 open-market purchases totaling $8.1M and 83 sales totaling $199.7M. That is a net selling position of $191.6M.

How many insiders trade ELV stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Elevance Health, Inc.. The most recent filing was accepted on Jul 17, 2026.

Where does Trabud get ELV insider trading data?

All ELV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content